Literature DB >> 25880938

The enduring effects of smoking in Latin America.

Alberto Palloni1, Beatriz Novak, Guido Pinto-Aguirre.   

Abstract

OBJECTIVES: We estimated smoking-attributable mortality, assessed the impact of past smoking on recent mortality, and computed expected future losses in life expectancy caused by past and current smoking behavior in Latin America and the Caribbean.
METHODS: We used a regression-based procedure to estimate smoking-attributable mortality and information for 6 countries (Argentina, Brazil, Chile, Cuba, Mexico, and Uruguay) for the years 1980 through 2009 contained in the Latin American Mortality Database (LAMBdA). These countries jointly comprise more than two thirds of the adult population in Latin America and the Caribbean and have the region's highest rates of smoking prevalence.
RESULTS: During the last 10 years, the impact of smoking was equivalent to losses in male (aged ≥ 50 years) life expectancy of about 2 to 6 years. These effects are likely to increase, particularly for females, both in the study countries and in those that joined the epidemic at later dates.
CONCLUSIONS: Unless innovations in the detection and treatment of chronic diseases are introduced soon, continued gains in adult survival in Latin America and the Caribbean region may slow down considerably.

Entities:  

Mesh:

Year:  2015        PMID: 25880938      PMCID: PMC4431107          DOI: 10.2105/AJPH.2014.302420

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  26 in total

1.  Tobacco industry success in Costa Rica: the importance of FCTC article 5.3.

Authors:  Eric Crosbie; Ernesto M Sebrié; Stanton A Glantz
Journal:  Salud Publica Mex       Date:  2012 Jan-Feb

2.  An international analysis of cigarette affordability.

Authors:  E H Blecher; C P van Walbeek
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

3.  Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003).

Authors:  Carlos Augusto Monteiro; Tania Maria Cavalcante; Erly Catarina Moura; Rafael Moreira Claro; Célia Landmann Szwarcwald
Journal:  Bull World Health Organ       Date:  2007-07       Impact factor: 9.408

4.  Cigarette affordability trends: an update and some methodological comments.

Authors:  E H Blecher; C P van Walbeek
Journal:  Tob Control       Date:  2009-01-29       Impact factor: 7.552

5.  Estimating the effect of smoking on slowdowns in mortality declines in developed countries.

Authors:  Brian L Rostron; John R Wilmoth
Journal:  Demography       Date:  2011-05

6.  Trends in cancer mortality in the Americas, 1970-2000.

Authors:  C Bosetti; M Malvezzi; L Chatenoud; E Negri; F Levi; C La Vecchia
Journal:  Ann Oncol       Date:  2005-01-24       Impact factor: 32.976

7.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

8.  Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom.

Authors:  M J Thun; L F Apicella; S J Henley
Journal:  JAMA       Date:  2000-08-09       Impact factor: 56.272

9.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.

Authors:  Ana Maria B Menezes; Rogelio Perez-Padilla; José Roberto B Jardim; Adriana Muiño; Maria Victorina Lopez; Gonzalo Valdivia; Maria Montes de Oca; Carlos Talamo; Pedro C Hallal; Cesar G Victora
Journal:  Lancet       Date:  2005-11-26       Impact factor: 79.321

10.  Attempts to undermine tobacco control: tobacco industry "youth smoking prevention" programs to undermine meaningful tobacco control in Latin America.

Authors:  Ernesto M Sebrié; Stanton A Glantz
Journal:  Am J Public Health       Date:  2007-06-28       Impact factor: 9.308

View more
  7 in total

1.  SES Gradients Among Mexicans in the United States and in Mexico: A New Twist to the Hispanic Paradox?

Authors:  Hiram Beltrán-Sánchez; Alberto Palloni; Fernando Riosmena; Rebeca Wong
Journal:  Demography       Date:  2016-10

2.  Mortality Trends for Lung Cancer and Smoking Prevalence In Peru.

Authors:  J Smith Torres-Roman; Bryan Valcarcel; Jose Fabian Martinez-Herrera; Janina Bazalar-Palacios; Carlo La Vecchia; Luis E Raez
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

3.  Clinical characteristics and PD-L1 expression in primary lung squamous cell carcinoma: A case series.

Authors:  Liliana Fernández-Trujillo; Juan E Garcia-Robledo; Valeria Zúñiga-Restrepo; Luz F Sua
Journal:  Respir Med Case Rep       Date:  2020-05-31

4.  Life expectancy with and without cognitive impairment among Chilean older adults: results of the National Survey of Health (2003, 2009 and 2016).

Authors:  Ximena Moreno; Lydia Lera; Francisco Moreno; Cecilia Albala
Journal:  BMC Geriatr       Date:  2019-12-26       Impact factor: 3.921

5.  Smoking-attributable mortality in South America: A systematic review.

Authors:  Alexandra Giraldo-Osorio; Mónica Pérez-Ríos; Julia Rey-Brandariz; Leonor Varela-Lema; Agustín Montes; Adriana Rodríguez-R; Nerea Mourino; Alberto Ruano-Ravina
Journal:  J Glob Health       Date:  2021-03-27       Impact factor: 4.413

6.  Cigarette smoking and metabolic syndrome components: a cross-sectional study from Maracaibo City, Venezuela.

Authors:  Valmore Bermudez; Luis Carlos Olivar; Wheeler Torres; Carla Navarro; Robys Gonzalez; Cristobal Espinoza; Alicia Morocho; Andres Mindiola; Maricarmen Chacin; Victor Arias; Roberto Añez; Juan Salazar; Manuel Riaño-Garzon; Edgar Diaz-Camargo; Maria Judith Bautista; Joselyn Rojas
Journal:  F1000Res       Date:  2018-05-10

7.  Optimizing Tobacco Advertising Bans in Seven Latin American Countries: Microsimulation Modeling of Health and Financial Impact to Inform Evidence-Based Policy.

Authors:  Ariel Bardach; Andrea Alcaraz; Javier Roberti; Agustín Ciapponi; Federico Augustovski; Andrés Pichon-Riviere
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.